Orange Book product · Generic (ANDA)
CEFOXITIN
CEFOXITIN SODIUM
At a glance
Jul 03, 2000
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 03, 2000
26 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFOXITIN SODIUM
Strength
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 065012
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFOXITIN SODIUM
- 2006CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINERBrand (NDA)
NDA 065214 · B BRAUN
- 1984MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 050581 · MERCK
- —MEFOXINBrand (NDA)
NDA 050517 · PHARMOBEDIENT
- 2015CEFOXITIN IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 200938 · SAMSON MEDCL
- 2011CEFOXITINGeneric (ANDA)
ANDA 065467 · ACS DOBFAR SPA
- 2011CEFOXITINGeneric (ANDA)
ANDA 065464 · ACS DOBFAR SPA
- 2010CEFOXITINGeneric (ANDA)
ANDA 065415 · ACS DOBFAR
- 2010CEFOXITINGeneric (ANDA)
ANDA 065238 · HIKMA FARMACEUTICA
- 2010CEFOXITINGeneric (ANDA)
ANDA 065239 · HIKMA FARMACEUTICA
- 2009CEFOXITINGeneric (ANDA)
ANDA 065414 · ACS DOBFAR
- 2006CEFOXITINGeneric (ANDA)
ANDA 065312 · HOSPIRA INC
- 2006CEFOXITINGeneric (ANDA)
ANDA 065313 · HOSPIRA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
